Sunosi

Sunosi · pharmadog

Patent cliff

source: FDA Orange Book

first barrier falls

Jun 11, 2031

~4.9 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (81)

Dec 30, 2042method-of-use (U-3693)US 11771666
Dec 30, 2042method-of-use (U-3693)US 11771666
Dec 30, 2042method-of-use (U-3693)US 11771667
Dec 30, 2042method-of-use (U-3693)US 11771667
Dec 30, 2042method-of-use (U-3693)US 11779554
Dec 30, 2042method-of-use (U-3693)US 11779554
Dec 30, 2042method-of-use (U-3693)US 11793776
Dec 30, 2042method-of-use (U-3693)US 11793776
Dec 30, 2042method-of-use (U-3693)US 11872203
Dec 30, 2042method-of-use (U-3693)US 11872203
Dec 30, 2042method-of-use (U-3693)US 11872204
Dec 30, 2042method-of-use (U-3693)US 11872204
Dec 30, 2042method-of-use (U-3693)US 12005036
Dec 30, 2042method-of-use (U-3693)US 12005036
Dec 30, 2042method-of-use (U-3693)US 12036194
Dec 30, 2042method-of-use (U-3693)US 12036194
Dec 30, 2042method-of-use (U-3693)US 12064411
Dec 30, 2042method-of-use (U-3693)US 12064411
Dec 30, 2042method-of-use (U-3693)US 12090126
Dec 30, 2042method-of-use (U-3693)US 12090126
Dec 30, 2042method-of-use (U-3693)US 12102609
Dec 30, 2042method-of-use (U-3693)US 12102609
Dec 30, 2042method-of-use (U-3693)US 12263145
Mar 19, 2040method-of-use (U-3099)US 10940133
Mar 19, 2040method-of-use (U-3521)US 11160779
Mar 19, 2040method-of-use (U-3521)US 11160779
Mar 19, 2040method-of-use (U-3765)US 11839598
Mar 19, 2040method-of-use (U-3765)US 11839598
Mar 19, 2040method-of-use (U-3764)US 11839599
Mar 19, 2040method-of-use (U-3764)US 11839599
Mar 19, 2040method-of-use (U-3775)US 11850226
Mar 19, 2040method-of-use (U-3775)US 11850226
Mar 19, 2040method-of-use (U-3775)US 11850227
Mar 19, 2040method-of-use (U-3775)US 11850227
Mar 19, 2040method-of-use (U-3775)US 11850228
Mar 19, 2040method-of-use (U-3775)US 11850228
Mar 19, 2040method-of-use (U-3521)US 11857528
Mar 19, 2040method-of-use (U-3521)US 11857528
Mar 19, 2040method-of-use (U-3892)US 11969404
Mar 19, 2040method-of-use (U-3892)US 11969404
Mar 19, 2040method-of-use (U-3775)US 11986454
Mar 19, 2040method-of-use (U-3775)US 11986454
Mar 19, 2040method-of-use (U-3521)US 11986455
Mar 19, 2040method-of-use (U-3521)US 11986455
Mar 19, 2040method-of-use (U-4106)US 12194016
Mar 19, 2040method-of-use (U-4106)US 12194016
Mar 19, 2040method-of-use (U-3765)US 12318362
Mar 6, 2039formulationUS 11560354
Mar 6, 2039formulationUS 11560354
Nov 1, 2038compositionUS 12384743
Nov 1, 2038compositionUS 12384743
Jun 1, 2038method-of-use (U-3082)US 10912754
Jun 1, 2038method-of-use (U-3082)US 10912754
Jun 1, 2038method-of-use (U-3151)US 10959976
Jun 1, 2038method-of-use (U-3151)US 10959976
Jun 1, 2038method-of-use (U-3602)US 11648232
Jun 1, 2038method-of-use (U-3602)US 11648232
Jun 1, 2038method-of-use (U-2548)US 11865098
Jun 1, 2038method-of-use (U-2548)US 11865098
Sep 5, 2037formulationUS 10195151
Sep 5, 2037formulationUS 10195151
Sep 5, 2037method-of-use (U-2548)US 10512609
Sep 5, 2037method-of-use (U-2548)US 10512609
Sep 5, 2037formulationUS 11439597
Sep 5, 2037formulationUS 11439597
Sep 5, 2037formulationUS 11998639
Sep 5, 2037formulationUS 11998639
Sep 5, 2037formulationUS 12390419
Sep 5, 2037formulationUS 12390419
Jun 11, 2031method-of-use (U-2548)US 84407154.9y
Jun 11, 2031method-of-use (U-2548)US 84407154.9y
Jun 7, 2026method-of-use (U-2548)US 10351517
Jun 7, 2026method-of-use (U-2548)US 10351517
Jun 7, 2026method-of-use (U-2548)US 11753368
Jun 7, 2026method-of-use (U-2548)US 11753368
Jun 7, 2026method-of-use (U-2548)US 12209059
Jun 7, 2026method-of-use (U-2548)US 12209059
Jun 7, 2026method-of-use (U-2548)US 8877806
Jun 7, 2026method-of-use (U-2548)US 8877806
Jun 7, 2026method-of-use (U-2548)US 9604917
Jun 7, 2026method-of-use (U-2548)US 9604917

FDA exclusivities (2)

Jun 17, 2026ODE-254Orphan Drug (7y)
Jun 17, 2026ODE-254Orphan Drug (7y)

solriamfetol hydrochloride

all catalysts(0)

News(0)

Patent cliff

patents (81)

FDA exclusivities (2)

comments(0)

Report a data issue

Trials studying solriamfetol hydrochloride